- Helldivers 2 Dev Says Farmers Are Okay, They’re Not Hurting the War Effort — but They’re Not Helping, Either IGN
- Helldivers 2 Players Are Kicking Teammates Who Don’t Have ‘Meta’ Loadouts IGN
- Helldivers 2: Best Loadouts, Ranked GameRant
- Undemocratic Helldivers 2 players off the hook as dev sets the record straight, confirming XP farmers aren’t helping the Automatons win Gamesradar
- Helldivers 2’s first big war isn’t suffering because of tough evac missions or medal-hoarding farmers—it’s the pass-or-fail reward structure that’s spoiling the fun PC Gamer
Tag Archives: hurting
Britney Spears guilty over ‘hurting’ Justin Timberlake in bombshell memoir: Report – The News International
- Britney Spears guilty over ‘hurting’ Justin Timberlake in bombshell memoir: Report The News International
- Britney Spears ‘Really Does Like’ Justin Timberlake’s New Song: Exclusive Sources PEOPLE
- Britney Spears Praises Justin Timberlake’s New Music, Says She’s “Deeply Sorry” for Offending People With Memoir Hollywood Reporter
- Britney Spears apologizes to Justin Timberlake, praises music after dueling ‘Selfish’ songs. Here’s what’s going on. Yahoo Entertainment
- Britney Spears Seems To Apologize To Justin Timberlake For Book, Praises His New Music HuffPost
Not brushing or flossing regularly? You could be hurting your body’s ability to fight off Alzheimer’s disease. What you need to know – Fortune
- Not brushing or flossing regularly? You could be hurting your body’s ability to fight off Alzheimer’s disease. What you need to know Fortune
- Health Alert Allentown: Gum Disease and Teeth Health Impact Your Brain Size. Doctor Explains 69News WFMZ-TV
- Long-term high fluoride exposure during adolescence causes hippocampal impairments News-Medical.Net
- Mirrorlights: Gum disease linked to buildup of Alzheimer’s plaque formation: Study Bangalore Mirror
- The connection between the plaque on your teeth and Alzheimer’s disease WKYC.com
- View Full Coverage on Google News
Mic’d-up video shows what Patrick Mahomes told Chiefs after hurting his ankle in Super Bowl 57 – USA TODAY
- Mic’d-up video shows what Patrick Mahomes told Chiefs after hurting his ankle in Super Bowl 57 USA TODAY
- Andy Reid did not allow Chiefs to watch Rihanna’s Super Bowl halftime show, Patrick Mahomes says Fox News
- Patrick Mahomes said coach Andy Reid threatened to bench any Chiefs player who tried to watch Rihanna’s Super Bowl halftime show msnNOW
- In case you missed Patrick Mahomes on Jimmy Kimmel, catch the segment here Missourinet.com
- Rob Gronkowski say Patrick Mahomes can give Tom Brady ‘a run for his money’ MassLive.com
- View Full Coverage on Google News
Brandon Staley on Chargers’ collapse: I’m hurting for everybody in that locker room
Chargers head coach Brandon Staley said after Saturday night’s epic collapse against the Jaguars that it hurt to see his players and coaches in pain.
After ratting off all the things the Chargers did well — including jumping out to a 27-0 lead and winning the turnover battle 5-0 — Staley acknowledged that it wasn’t enough.
“I’m hurting for everybody in that locker room,” Staley said. “It’s a special group of guys and this is the toughest way that you can lose, in the playoffs. The way we started the game, that’s the team I know we’re capable of being, and in the second half we just didn’t finish the game. Unfortunately, this is the tough side of things. Our season is over, but I love everybody in that locker room.”
Staley said he believes the Chargers will grow and get better from the loss. But the big question is whether Staley will be there for that growth and improvement. He’s squarely on the hot seat after his team melted down in the playoffs.
Why U.S tech controls on China, could end up hurting American semiconductors
When the US first banned sales of certain tech products to Chinese tech firm Huawei three years ago, it crippled a once-proud national champion and sent ripples across the US semiconductor industry. In the quarters following that export ban in May 2019, top American chipmakers reported a median revenue decline of 4% to 9%.
The Biden administration’s latest tech controls threaten to accelerate those losses, throwing the global semiconductor sector into disarray. And Chinese companies targeted by the new regulations won’t be the only ones feeling the pain.
“If China really wants to be as aggressive as the US and retaliate, there could be a lot of impact for other companies in the US,” said Edith Yeung, Race Capital General Partner, in an interview with Yahoo Finance Live (video above). “This is beyond impact on revenue for Intel (INTC) or Qualcomm (QCOM) or NVIDIA (NVDA).”
The US has long been a global leader in semiconductors, commanding roughly 45% to 50% market share. However, that leadership has been built on global demand for its products, with China consuming roughly 75% of semiconductors sold globally.
Chinese device makers alone accounted for roughly a quarter of global semiconductor demand in 2018, according to a study by Boston Consulting Group (BCG).
‘More than just a preventative tool’
That innovation cycle is at risk of being picked apart, with the Biden administration’s sweeping tech controls, aimed at freezing China’s semiconductor development and dramatically limiting critical technology exports from the US
“Technology export controls can be more than just a preventative tool,” said National Security Adviser Jake Sullivan, ahead of the administration’s announcements. “If implemented in a way that is robust, durable, and comprehensive, they can be a new strategic asset in the US and allied toolkit to impose costs on adversaries, and even over time degrade their battlefield capabilities.”
‘A sea change’ in policy
Specifically, the new measures block sales of semiconductors critical to the development of artificial intelligence, supercomputers, and other advanced technologies, unless companies receive exemptions. It also expands an existing ban to sell advanced chip-making equipment to Chinese firms.
In a broad escalation, the Biden administration’s actions also restrict US firms and citizens, including permanent residents, from supporting China’s development of advanced chips.
The restrictions announced earlier this month have already created a chilling effect.
At least 43 senior executives are American citizens working with 16 publicly listed Chinese semiconductor companies, according to the Wall Street Journal. Western firms like Dutch equipment maker ASML Holding NV have suspended American employees from working as a precaution, while they seek further clarity. What’s more, Apple temporarily halted plans to use memory chips from China’s Yangtze Memory Technologies Co. in products, according to Nikkei Asia.
“This is really a sea change in policy… the U.S. is imposing a freeze-in-place strategy toward China’s indigenous chip development,” said Reva Goujon, Rhodium Group Director. “[The semiconductor sector] is an interdependent, interlocking ecosystem where all the parts kind of have to be in place for things to work to be able to upgrade to more and more advanced levels. So, if you cut the legs out from under that production cycle, you can really cause a lot of disruption, which is exactly what the US intent is.”
Impact on US chipmakers
The disruption may not be limited to Chinese firms. A 2020 study by BCG estimated that US companies could lose 18% of their global market share and 37% of their revenues over the same period if the US completely bans semiconductor companies from selling to Chinese customers.
The measures have already prompted chip equipment maker Applied Materials to cut fourth-quarter estimates for net sales by approximately $400 million. Q4 non-GAAP adjusted diluted EPS is expected to range from $1.54 to $1.78, compared to the prior range of $1.82 to $2.18.
While the restrictions are limited to next-generation chips now, NVIDIA, the largest US chipmaker by market value, warned in August that new licensing requirement on advanced chip shipments to China could cost the firm as much as $400 million in quarterly sales.
“There’s certainly a chance this could have a much bigger waterfall effect but I think these companies have already looked at the situation, they’re assessing it,” said Daniel Newman, Founding Partner and Principal Analyst at Futurum Research. “I’m not overly alarmed that it’s going to be the whole portfolio [of chips]… I think this is about leading the arms race for the next generation of technology in areas like supercomputing, high-performance computing, and artificial intelligence.”
Containing technology ‘where they need to be’
Secretary of State Anthony Blinken has reiterated as much, highlighting in a recent address at Stanford University, that only “a small number of countries” are manufacturing or making tools to manufacture the highest-end semiconductors.
“We want to make sure that we keep those where they need to be,” Blinken said, without singling out China.
But Goujon argues that US firms, particularly equipment makers, face the risk of losing market share and revenue to competitors in countries that have historically had friendlier relations with the US, including Japan and South Korea. If companies there find a workaround for the Biden administration’s measures, Goujon said the new controls could end up backfiring on the US
“Foreign competitors to US [equipment makers] have an opportunity here, of course, to try to capture more market share in China if they can displace US persons and US linkages, which is possible in some areas,” she said.
“The US is applying heavy bilateral and plurilateral pressure for partners to follow its lead, and it’s sending the signal that look, This package contains extraterritorial measures and we will add more if needed. But here’s the window to try to basically align with our controls. So that’s really going to be an important question now.”
Akiko Fujita is an anchor and reporter for Yahoo Finance. Follow her on Twitter @AkikoFujita
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube
Why U.S tech controls on China, could end up hurting American semiconductors
When the US first banned sales of certain tech products to Chinese tech firm Huawei three years ago, it crippled a once-proud national champion and sent ripples across the US semiconductor industry. In the quarters following that export ban in May 2019, top American chipmakers reported a median revenue decline of 4% to 9%.
The Biden administration’s latest tech controls threaten to accelerate those losses, throwing the global semiconductor sector into disarray. And Chinese companies targeted by the new regulations won’t be the only ones feeling the pain.
“If China really wants to be as aggressive as the US and retaliate, there could be a lot of impact for other companies in the US,” said Edith Yeung, Race Capital General Partner, in an interview with Yahoo Finance Live (video above). “This is beyond impact on revenue for Intel (INTC) or Qualcomm (QCOM) or NVIDIA (NVDA).”
The US has long been a global leader in semiconductors, commanding roughly 45% to 50% market share. However, that leadership has been built on global demand for its products, with China consuming roughly 75% of semiconductors sold globally.
Chinese device makers alone accounted for roughly a quarter of global semiconductor demand in 2018, according to a study by Boston Consulting Group (BCG).
‘More than just a preventative tool’
That innovation cycle is at risk of being picked apart, with the Biden administration’s sweeping tech controls, aimed at freezing China’s semiconductor development and dramatically limiting critical technology exports from the US
“Technology export controls can be more than just a preventative tool,” said National Security Adviser Jake Sullivan, ahead of the administration’s announcements. “If implemented in a way that is robust, durable, and comprehensive, they can be a new strategic asset in the US and allied toolkit to impose costs on adversaries, and even over time degrade their battlefield capabilities.”
‘A sea change’ in policy
Specifically, the new measures block sales of semiconductors critical to the development of artificial intelligence, supercomputers, and other advanced technologies, unless companies receive exemptions. It also expands an existing ban to sell advanced chip-making equipment to Chinese firms.
In a broad escalation, the Biden administration’s actions also restrict US firms and citizens, including permanent residents, from supporting China’s development of advanced chips.
The restrictions announced earlier this month have already created a chilling effect.
At least 43 senior executives are American citizens working with 16 publicly listed Chinese semiconductor companies, according to the Wall Street Journal. Western firms like Dutch equipment maker ASML Holding NV have suspended American employees from working as a precaution, while they seek further clarity. What’s more, Apple temporarily halted plans to use memory chips from China’s Yangtze Memory Technologies Co. in products, according to Nikkei Asia.
“This is really a sea change in policy… the U.S. is imposing a freeze-in-place strategy toward China’s indigenous chip development,” said Reva Goujon, Rhodium Group Director. “[The semiconductor sector] is an interdependent, interlocking ecosystem where all the parts kind of have to be in place for things to work to be able to upgrade to more and more advanced levels. So, if you cut the legs out from under that production cycle, you can really cause a lot of disruption, which is exactly what the US intent is.”
Impact on US chipmakers
The disruption may not be limited to Chinese firms. A 2020 study by BCG estimated that US companies could lose 18% of their global market share and 37% of their revenues over the same period if the US completely bans semiconductor companies from selling to Chinese customers.
The measures have already prompted chip equipment maker Applied Materials to cut fourth-quarter estimates for net sales by approximately $400 million. Q4 non-GAAP adjusted diluted EPS is expected to range from $1.54 to $1.78, compared to the prior range of $1.82 to $2.18.
While the restrictions are limited to next-generation chips now, NVIDIA, the largest US chipmaker by market value, warned in August that new licensing requirement on advanced chip shipments to China could cost the firm as much as $400 million in quarterly sales.
“There’s certainly a chance this could have a much bigger waterfall effect but I think these companies have already looked at the situation, they’re assessing it,” said Daniel Newman, Founding Partner and Principal Analyst at Futurum Research. “I’m not overly alarmed that it’s going to be the whole portfolio [of chips]… I think this is about leading the arms race for the next generation of technology in areas like supercomputing, high-performance computing, and artificial intelligence.”
Containing technology ‘where they need to be’
Secretary of State Anthony Blinken has reiterated as much, highlighting in a recent address at Stanford University, that only “a small number of countries” are manufacturing or making tools to manufacture the highest-end semiconductors.
“We want to make sure that we keep those where they need to be,” Blinken said, without singling out China.
But Goujon argues that US firms, particularly equipment makers, face the risk of losing market share and revenue to competitors in countries that have historically had friendlier relations with the US, including Japan and South Korea. If companies there find a workaround for the Biden administration’s measures, Goujon said the new controls could end up backfiring on the US
“Foreign competitors to US [equipment makers] have an opportunity here, of course, to try to capture more market share in China if they can displace US persons and US linkages, which is possible in some areas,” she said.
“The US is applying heavy bilateral and plurilateral pressure for partners to follow its lead, and it’s sending the signal that look, This package contains extraterritorial measures and we will add more if needed. But here’s the window to try to basically align with our controls. So that’s really going to be an important question now.”
Akiko Fujita is an anchor and reporter for Yahoo Finance. Follow her on Twitter @AkikoFujita
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube
Chet Holmgren injury update: Thunder rookie out entire 2022-23 season after hurting right foot at Pro-Am
Chet Holmgren, the Oklahoma City Thunder’s No. 2 overall pick in the 2022 NBA Draft, will miss the entire 2022-23 season, the team announced Thursday. Holmgren suffered a Lisfranc injury to his right foot.
“Certainly, we are disappointed for Chet, especially given the excitement he had about getting on the floor with his teammates this season,” Thunder general manager Sam Presti said in a statement. “We know Chet has a long career aead of him within our organization and the Oklahoma City community. One of the things that most impressed us during the process of selecting Chet was his determination and focus. We expect that same tenacity will carry him through this period of time as we work together and support him during his rehabilitation.”
Holmgren was playing at Jamal Crawford’s “The Crawsover Pro-Am” in Seattle last weekend and at one point went up to defend LeBron James at the rim. He appeared to land awkwardly and was limping as he tried to make his way back down the court. He left the game after that play and a short time later the entire event was called off due to condensation on the court. (His injury did not seem to be related to the court issue.)
This is obviously disappointing news for both him and the Thunder. Holmgren impressed on both ends of the floor during Summer League action in Salt Lake City and Las Vegas, which generated even more excitement for his eventual NBA debut.
Please check the opt-in box to acknowledge that you would like to subscribe.
Thanks for signing up!
Keep an eye on your inbox.
Sorry!
There was an error processing your subscription.
In his first game in Salt Lake City, he dropped 23 points, seven rebounds, four assists and six blocks; over three games in Vegas he averaged 12 points, 7.7 rebounds, 2.3 assists, 2.3 steals and two blocks. Sure, you can only read so much into Summer League stats, but his ability to impact the game in so many different ways was exactly why the Thunder were eager to make him the second overall pick.
Heading into the draft, one of the few concerns about Holmgren was in regards to his body. Many had questions about how his spindly, 7-foot, 195-pound body would hold up to the rigors of the professional game. Some may use this injury as proof that they were right, but it’s worth noting this was a fluke play and landing on someone’s foot under the basket can happen to anyone.
require.config({"baseUrl":"https://sportsfly.cbsistatic.com/fly-0304/bundles/sportsmediajs/js-build","config":{"version":{"fly/components/accordion":"1.0","fly/components/alert":"1.0","fly/components/base":"1.0","fly/components/carousel":"1.0","fly/components/dropdown":"1.0","fly/components/fixate":"1.0","fly/components/form-validate":"1.0","fly/components/image-gallery":"1.0","fly/components/iframe-messenger":"1.0","fly/components/load-more":"1.0","fly/components/load-more-article":"1.0","fly/components/load-more-scroll":"1.0","fly/components/loading":"1.0","fly/components/modal":"1.0","fly/components/modal-iframe":"1.0","fly/components/network-bar":"1.0","fly/components/poll":"1.0","fly/components/search-player":"1.0","fly/components/social-button":"1.0","fly/components/social-counts":"1.0","fly/components/social-links":"1.0","fly/components/tabs":"1.0","fly/components/video":"1.0","fly/libs/easy-xdm":"2.4.17.1","fly/libs/jquery.cookie":"1.2","fly/libs/jquery.throttle-debounce":"1.1","fly/libs/jquery.widget":"1.9.2","fly/libs/omniture.s-code":"1.0","fly/utils/jquery-mobile-init":"1.0","fly/libs/jquery.mobile":"1.3.2","fly/libs/backbone":"1.0.0","fly/libs/underscore":"1.5.1","fly/libs/jquery.easing":"1.3","fly/managers/ad":"2.0","fly/managers/components":"1.0","fly/managers/cookie":"1.0","fly/managers/debug":"1.0","fly/managers/geo":"1.0","fly/managers/gpt":"4.3","fly/managers/history":"2.0","fly/managers/madison":"1.0","fly/managers/social-authentication":"1.0","fly/utils/data-prefix":"1.0","fly/utils/data-selector":"1.0","fly/utils/function-natives":"1.0","fly/utils/guid":"1.0","fly/utils/log":"1.0","fly/utils/object-helper":"1.0","fly/utils/string-helper":"1.0","fly/utils/string-vars":"1.0","fly/utils/url-helper":"1.0","libs/jshashtable":"2.1","libs/select2":"3.5.1","libs/jsonp":"2.4.0","libs/jquery/mobile":"1.4.5","libs/modernizr.custom":"2.6.2","libs/velocity":"1.2.2","libs/dataTables":"1.10.6","libs/dataTables.fixedColumns":"3.0.4","libs/dataTables.fixedHeader":"2.1.2","libs/dateformat":"1.0.3","libs/waypoints/infinite":"3.1.1","libs/waypoints/inview":"3.1.1","libs/waypoints/jquery.waypoints":"3.1.1","libs/waypoints/sticky":"3.1.1","libs/jquery/dotdotdot":"1.6.1","libs/jquery/flexslider":"2.1","libs/jquery/lazyload":"1.9.3","libs/jquery/maskedinput":"1.3.1","libs/jquery/marquee":"1.3.1","libs/jquery/numberformatter":"1.2.3","libs/jquery/placeholder":"0.2.4","libs/jquery/scrollbar":"0.1.6","libs/jquery/tablesorter":"2.0.5","libs/jquery/touchswipe":"1.6.18","libs/jquery/ui/jquery.ui.core":"1.11.4","libs/jquery/ui/jquery.ui.draggable":"1.11.4","libs/jquery/ui/jquery.ui.mouse":"1.11.4","libs/jquery/ui/jquery.ui.position":"1.11.4","libs/jquery/ui/jquery.ui.slider":"1.11.4","libs/jquery/ui/jquery.ui.sortable":"1.11.4","libs/jquery/ui/jquery.ui.touch-punch":"0.2.3","libs/jquery/ui/jquery.ui.autocomplete":"1.11.4","libs/jquery/ui/jquery.ui.accordion":"1.11.4","libs/jquery/ui/jquery.ui.tabs":"1.11.4","libs/jquery/ui/jquery.ui.menu":"1.11.4","libs/jquery/ui/jquery.ui.dialog":"1.11.4","libs/jquery/ui/jquery.ui.resizable":"1.11.4","libs/jquery/ui/jquery.ui.button":"1.11.4","libs/jquery/ui/jquery.ui.tooltip":"1.11.4","libs/jquery/ui/jquery.ui.effects":"1.11.4","libs/jquery/ui/jquery.ui.datepicker":"1.11.4"}},"shim":{"liveconnection/managers/connection":{"deps":["liveconnection/libs/sockjs-0.3.4"]},"liveconnection/libs/sockjs-0.3.4":{"exports":"SockJS"},"libs/setValueFromArray":{"exports":"set"},"libs/getValueFromArray":{"exports":"get"},"fly/libs/jquery.mobile-1.3.2":["version!fly/utils/jquery-mobile-init"],"libs/backbone.marionette":{"deps":["jquery","version!fly/libs/underscore","version!fly/libs/backbone"],"exports":"Marionette"},"fly/libs/underscore-1.5.1":{"exports":"_"},"fly/libs/backbone-1.0.0":{"deps":["version!fly/libs/underscore","jquery"],"exports":"Backbone"},"libs/jquery/ui/jquery.ui.tabs-1.11.4":["jquery","version!libs/jquery/ui/jquery.ui.core","version!fly/libs/jquery.widget"],"libs/jquery/flexslider-2.1":["jquery"],"libs/dataTables.fixedColumns-3.0.4":["jquery","version!libs/dataTables"],"libs/dataTables.fixedHeader-2.1.2":["jquery","version!libs/dataTables"],"https://sports.cbsimg.net/js/CBSi/app/VideoPlayer/AdobePass-min.js":["https://sports.cbsimg.net/js/CBSi/util/Utils-min.js"]},"map":{"*":{"adobe-pass":"https://sports.cbsimg.net/js/CBSi/app/VideoPlayer/AdobePass-min.js","facebook":"https://connect.facebook.net/en_US/sdk.js","facebook-debug":"https://connect.facebook.net/en_US/all/debug.js","google":"https://apis.google.com/js/plusone.js","google-platform":"https://apis.google.com/js/client:platform.js","google-csa":"https://www.google.com/adsense/search/async-ads.js","google-javascript-api":"https://www.google.com/jsapi","google-client-api":"https://apis.google.com/js/api:client.js","gpt":"https://securepubads.g.doubleclick.net/tag/js/gpt.js","hlsjs":"https://cdnjs.cloudflare.com/ajax/libs/hls.js/1.0.7/hls.js","recaptcha":"https://www.google.com/recaptcha/api.js?onload=loadRecaptcha&render=explicit","recaptcha_ajax":"https://www.google.com/recaptcha/api/js/recaptcha_ajax.js","supreme-golf":"https://sgapps-staging.supremegolf.com/search/assets/js/bundle.js","taboola":"https://cdn.taboola.com/libtrc/cbsinteractive-cbssports/loader.js","twitter":"https://platform.twitter.com/widgets.js","video-avia":"https://vidtech.cbsinteractive.com/avia-js/2.4.0/player/avia.min.js","video-avia-ui":"https://vidtech.cbsinteractive.com/avia-js/2.4.0/plugins/ui/avia.ui.min.js","video-avia-gam":"https://vidtech.cbsinteractive.com/avia-js/2.4.0/plugins/gam/avia.gam.min.js","video-avia-hls":"https://vidtech.cbsinteractive.com/avia-js/2.4.0/plugins/hls/avia.hls.min.js","video-avia-playlist":"https://vidtech.cbsinteractive.com/avia-js/2.4.0/plugins/playlist/avia.playlist.min.js","video-ima3":"https://imasdk.googleapis.com/js/sdkloader/ima3.js","video-ima3-dai":"https://imasdk.googleapis.com/js/sdkloader/ima3_dai.js","video-utils":"https://sports.cbsimg.net/js/CBSi/util/Utils-min.js","video-vast-tracking":"https://vidtech.cbsinteractive.com/sb55/vast-js/vtg-vast-client.js"}},"waitSeconds":300});
Lack of ‘high quality’ clinical guidelines for monkeypox may be hurting treatment efforts, researchers say – The Hill
Story at a glance
- A team of researchers mainly from the University of Oxford looked at 14 clinical guidelines for monkeypox and found that most of them were “low quality.”
- Researchers said the guidelines lacked sufficient detail on the virus and contradictory treatment recommendations.
- The lack of standardization of these clinical guidelines could be hurting global efforts to treat people with the disease.
A lack of up-to-date clinical guidelines on monkeypox may be impacting health care workers’ ability to administer effective and safe treatment in those infected, according to researchers.
U.K.-based researchers looked at the existing clinical guidelines available for the disease and found that they often lack sufficient detail, are contradictory in their recommendations and fail to include impacts of the illness on different groups including children.
The findings of the analysis were published earlier this week in the journal BMI Global Health.
America is changing faster than ever! Add Changing America to your Facebook or Twitter feed to stay on top of the news.
Monkeypox is a viral disease that belongs to the same family as smallpox that can show up as a rash made up of small and painful blisters. Symptoms of the illness can also include fever, chills, fatigue, muscle aches, cough, neck pain and swollen lymph nodes.
There has been an outbreak of the rare disease this summer with the U.S. Centers for Disease Control and Prevention confirming 14,115 cases of the virus across the country as of Thursday.
Before the 2022 outbreak, the disease had been mainly reported in people living in about a dozen central and western African countries, according to the CDC.
Now, a worldwide jump in cases has prompted the World Health Organization to declare the spike a public health emergency.
In their analysis, researchers parsed through six major research databases with relevant information on monkeypox published up to October of last year and other “grey literature” like policy documents, newsletters and reports in multiple languages published until this May. They found a total of 14 relevant clinical guidelines, most of which were “low quality” and only covered a range of topics.
Only five out of the 14 clinical guidelines gave any guidance on how to care for children infected with the virus and only three had any advice on how to treat pregnant women or people living with HIV who had contracted the disease, according to the analysis findings.
Monkeypox treatment guidance was mostly limited to advice on antiviral medication and was not consistent, researchers added. Out of the guidelines reviewed, seven recommended that patients with monkeypox be given cidofovir, and out of those seven only four noted that the medication be only administered to treat severe infections.
Only four clinical guidelines recommended tecovirimat and one advised giving the sick brincidofovir.
Currently, the WHO recommends that health care professionals use tecovirimat to treat monkeypox patients instead of cidofovir.
None of the clinical guidelines reviewed contained details on optimal doses, timing or length of treatment and only one had any recommendations on supportive care and treatment complications, according to the findings.
Every one of the 14 guidelines encouraged vaccination as post-exposure prophylaxis but not all of them had up to date information on the newer generation of vaccines.
Guidelines are key tools for clinicians and are especially important for emerging infectious diseases that health care workers might be less familiar with, according to Louise Sigfrid, who works at the ISARIC Global Support Center, Pandemic Sciences Institute at the University of Oxford and is one of the lead researchers in the analysis.
Sigfrid noted that some of her colleagues in London that treated monkeypox patients early in the U.K.’s outbreak this spring reported struggling to know how to diagnose and treat patients due to limited guidelines.
“The main aim of the clinical national guidelines is to benefit patient care,” Sigfrid told Changing America. “It’s also to standardize care. To make sure that all patients in all settings have access to evidence-based care and that clinicians have access to evidence-based treatments.”
Standardizing clinical guidelines also serves an important purpose when it comes to developing vaccines for diseases like monkeypox, Sigfrid added. Without them, clinical research for treatments can be weakened and hamper randomized control trials.
“As rare diseases are emerging…what we have also seen when we are trying to implement rapidly is that clinicians in different sites will use different treatments,” said Sigfrid.
READ MORE STORIES FROM CHANGING AMERICA
BLIND WOMAN CAN SEE SHAPES WITH HELP FROM NEW BRAIN IMPLANTS
RATS RUNNING THROUGH VR MAZE OFFER INSIGHTS ON MEMORY AND LEARNING
AUTO-INJECTING PILL COULD DELIVER DRUGS NORMALLY GIVEN BY SHOTS
IN A BREAKTHROUGH CARTILAGE FROM NOSE IS USED TO TREAT SEVERE KNEE PROBLEMS
Published on Aug. 19, 2022
PFAS ‘Forever Chemicals’ Might Be Hurting Our Livers, Study Finds
New research finds evidence that per- and polyfluoroalkyl substances, known as PFAS, can damage people’s livers over time. The study, a review of the evidence in both rodents and humans, might also show that PFAS exposure can contribute to nonalcoholic fatty liver disease, a chronic metabolic condition that’s become more common.
PFAS are synthetic chemicals often used in manufacturing, particularly in plastic products or cosmetics. But because PFAS don’t break down easily, they’ve ended up just about everywhere in the environment—earning them the grim nickname of forever chemicals. This ubiquity extends to living things as well, with many people and wildlife having detectable levels of PFAS in their bodies at any given time.
These chemicals unfortunately aren’t harmless. They’re known to mimic or otherwise disturb the body’s hormones, which may raise the risk of various health problems, including cancer and infertility. This new research, published Wednesday in Environmental Health Perspectives, suggests that the liver isn’t spared from the effects of PFAS.
The researchers, based at the University of Southern California, looked at data from over 100 studies that involved either rodents or humans. Overall, they found a link between higher levels of PFAS in the body and higher levels of alanine aminotransferase (ALT), an enzyme produced by the liver. That’s a worrying connection, because high ALT levels in the blood are a common sign of liver damage.
“The major takeaway from this review is the comprehensive evidence across animal, population, and occupational studies that PFAS exposure is linked to liver damage,” lead author Sarah Rock, a PhD student in the department of population and public health sciences at USC’s Keck School of Medicine, told Gizmodo in an email. “These findings contribute to the growing evidence that PFAS may play a role in development of multiple diseases.”
In animals, Rock and her team also found a clear link between greater PFAS exposure and nonalcoholic fatty liver disease (NAFLD), which is characterized by an accumulation of fat in the liver that’s not caused by chronic drinking. NAFLD often causes no symptoms on its own, though people can experience fatigue and abdominal pain. Sometimes, though, the buildup of fat can cause damaging liver inflammation, a condition called nonalcoholic steatohepatitis (NASH). People with NASH are then more likely to develop serious complications such as permanent scarring, internal bleeding, and complete liver failure.
Rates of NAFLD and NASH have been steadily climbing in the U.S. and elsewhere in recent decades, alongside rates of important risk factors for NAFLD such as obesity and type 2 diabetes (in the U.S., a quarter of adults are estimated to have it). The latest findings might show that chronic exposure to PFAS has had some role in this increase, but it’ s been hard and costly to study NAFLD, the authors say. So far, there’s been little research in humans that’s tried to figure out whether PFAS could be a contributing factor. That said, higher levels of ALT in people can be a sign of fatty liver disease as well, and other studies have found a link between PFAS and other possible biomarkers, such as high blood cholesterol.
Another limitation in studying the negative health effects of PFAS chemicals in general is that there are many such chemicals out there, and people are exposed to them in many different ways. That makes it difficult to tease out which ones are harming us and how they’re getting into our bodies. In this review, the team isolated three specific PFAS—perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS) and perfluorononanoic acid (PFNA)—as being associated with signs of liver damage.
The researchers say that more studies will be needed to isolate the complex nature of PFAS exposure on the liver. But at the very least, they add, their findings show that these chemicals are a potential health threat and that more has to be done about them—a sentiment that many scientists are in agreement about.
“Evidence from this study on liver injury, alongside the work of many other researchers examining PFAS exposure and other disease outcomes, suggest that we should be doing more to not only phase out PFAS use and but also actively remove it from our environment,” Rock said.